Breaking News

Lonza Expands HPAPI Suite for Payload-Linker Manufacturing

Adds further capacity in Visp for the manufacturing of antibody-drug conjugate payloads.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, has completed the expansion of its highly potent API (HPAPI) multipurpose suite in Visp, Switzerland. The expansion adds development and manufacturing capacity for ADC payloads, supporting the entire development and manufacturing pipeline from feasibility studies to commercial supply. The expansion underlines the strategic position of ADCs in Lonza’s portfolio. Lonza develops and produces al...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters